PFS Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-58,756
Closed -$2.77K 465
2022
Q3
$2.77K Buy
58,756
+596
+1% +$38.5K 0.05% 243
2022
Q2
$4.17M Buy
58,160
+14,748
+34% +$1.08M 0.08% 203
2022
Q1
$3.51M Buy
43,412
+141
+0.3% +$11.9K 0.07% 230
2021
Q4
$4.44M Buy
43,271
+10,503
+32% +$1.01M 0.09% 203
2021
Q3
$3.33M Buy
+32,768
New +$2.97M 0.07% 222

Other funds holding SYNH

PFS Investments's SYNH Position: Q4 2022 in Review

PFS Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 58,756 shares — an estimated $2.77K sold.

PFS Investments first reported a position in SYNH in Q3 2021 and held it in 5 quarters. The position peaked at $4.44M in Q4 2021. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • PFS Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • PFS Investments sold 58,756 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $2.77K.
  • PFS Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 5 quarters.
  • PFS Investments's Syneos Health, Inc. Class A Common Stock position peaked at $4.44M in Q4 2021.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on PFS Investments's 13F filing for Q4 2022, filed 14 Feb 2023.